Publication Name	World Journal of Cardiology
Manuscript ID	65783
Country	United Kingdom

Received	2021-03-15 21:52
Peer-Review Started	2021-03-15 22:01
To Make the First Decision
Return for Revision	2021-04-26 23:05
Revised	2021-05-19 10:35
Second Decision	2021-07-26 03:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-07-26 08:05
Articles in Press	2021-07-26 08:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-08-10 06:50
Publish the Manuscript Online	2021-08-23 13:28

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Academic Activity Report
Article Title	Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era
Manuscript Source	Invited Manuscript
All Author List	Jennie Han and Nadeem Attar
ORCID	Author(s) ORCID Number Jennie Han http://orcid.org/0000-0002-7089-8923 Nadeem Attar http://orcid.org/0000-0002-7087-6441
Funding Agency and Grant Number
Corresponding Author	Jennie Han, BM BCh, Doctor, Research Fellow, Department of Cardiology, Royal Lancaster Infirmary, Ashton Road, Lancaster LA1 4RP, Lancashire, United Kingdom. jenniehan95@gmail.com
Key Words	Coronary artery disease; Drug-eluting stent; Percutaneous coronary intervention; Dual antiplatelet therapy; Stent thrombosis; Target lesion revascularization
Core Tip	The new generation of drug-eluting stents have different properties such as reduced strut thickness allowing lower level of local stent thrombosis, which may be feasible with shortened dual antiplatelet therapy (DAPT). Only a small number of individual stents have been validated for reduced DAPT, such as 1 mo for the BioFreedom stainless steel biolimus-eluting stent and the Onyx Resolute cobalt-chromium zotarolimus-eluting stent but in only certain populations. Future trials will compare DAPT durations within the same stent. Future research should also examine risk stratification and the parameters for patients to benefit the most from shortened DAPT.
Publish Date	2021-08-23 13:28
Citation	Han J, Attar N. Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era. World J Cardiol 2021; 13(8): 243-253
URL	https://www.wjgnet.com/1949-8462/full/v13/i8/243.htm
DOI	https://dx.doi.org/10.4330/wjc.v13.i8.243

Full Article (PDF)	WJC-13-243.pdf
Full Article (Word)	WJC-13-243.docx
Manuscript File	65783_Auto_Edited-JPY.docx
Answering Reviewers	65783-Answering reviewers.pdf
Audio Core Tip	65783-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	65783-Conflict-of-interest statement.pdf
Copyright License Agreement	65783-Copyright license agreement.pdf
Peer-review Report	65783-Peer-review(s).pdf
Scientific Misconduct Check	65783-Scientific misconduct check.pdf
Scientific Editor Work List	65783-Scientific editor work list.pdf